Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre Randomised Controlled Trial Evaluating the Efficacy of the Four-component Meningococcal B Vaccine, 4CMenB (Bexsero®), in the Prevention of Neisseria Gonorrhoeae Infection in Gay and Bisexual Men

NCT04415424 is registered in ClinicalTrials.gov with Kirby Institute as lead sponsor.

NCT NCT04415424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04415424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre Randomised Controlled Trial Evaluating the Efficacy of the Four-component Meningococcal B Vaccine, 4CMenB (Bexsero®), in the Prevention of Neisseria Gonorrhoeae Infection in Gay and Bisexual Men
Lead sponsor
Kirby Institute
Phase
Phase 3
Overall status
Active, not recruiting
Start date
July 8, 2021
Completion date
October 30, 2025
Enrollment
650 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

neisseria gonorrheae infection